CAMPTON Diagnostics develops molecular biological and serological test for CORONA on Reader 100 for almost simultaneous measurement of both tests
22003
post-template-default,single,single-post,postid-22003,single-format-standard,cookies-not-set,stockholm-core-1.2.1,select-theme-ver-5.2.1,ajax_leftright,page_not_loaded,wpb-js-composer js-comp-ver-6.1,vc_responsive

CAMPTON Diagnostics develops molecular biological and serological test for CORONA on Reader 100 for almost simultaneous measurement of both tests

CAMPTON Diagnostics develops molecular biological and serological test for CORONA on Reader 100 for almost simultaneous measurement of both tests

The aim of the development work is to have both test variants available by around September 2020.


The technology of our reader was originally developed for the protein analysis procedure and is currently being extended to DNA analysis. At present, we are not aware of any competing system on the market that can measure with both methods almost in parallel using different cartridges from a blood sample and a smear.


Further information